States Strive To Curb Costs For A Crucial 鈥 But Exorbitant 鈥 Hemophilia Treatment
Saving the lives of people with the bleeding disorder can require high doses of expensive blood-clotting factor. Taxpayers foot much of the bill as manufacturers profit enormously.